KISSEI PHARMACEUTICAL
KISSEI PHARMACEUTICAL
Social Links:
Industry:
Agriculture Biotechnology Food And Beverage
Status:
Active
Technology used in webpage:
SPF Google Universal Analytics Domain Not Resolving Mobile Non Scaleable Content Sitelinks Search Box Amazon Microsoft Azure DNS COVID-19 ASP.NET Amazon Route 53
Current Employees Featured
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-12-10 | CG Oncology | Kissei Pharmaceutical investment in Series D - CG Oncology | 47 M USD |
More informations about "Kissei Pharmaceutical"
Kissei - Wikipedia
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include: [1] Difelikefalin; Fostamatinib (trade name …See details»
English Home | KISSEI PHARMACEUTICAL CO.,LTD.
Nov 5, 2024 Looking Towards Tomorrow's Health. KISSEI PHARMACEUTICAL CO.,LTD. March 14, 2025. Kissei Initiates Additional Phase III Clinical Trial for Rovatirelin (KPS-0373) for the Treatment of Spinocerebellar DegenerationSee details»
About Kissei | English Home | KISSEI …
Kissei Pharmaceutical Co., Ltd. Message. Contribute to the health of people around the world through innovative pharmaceutical products.See details»
KISSEI’s Company Profile - ジェトロ（日本貿易振興機構）
Operational Organization 4 Sales Force: 10 Sales Branches 50 Offices Joetsu Chemical Laboratory Tokyo Main Offices: Nihonbashi, Koishikawa Matsumoto Area Headquarters …See details»
KISSEI Company Profile - ジェトロ（日本貿易振興機構）
Overseas Subsidiary: Kissei America Inc. (Fort Lee, NJ) Background image : Matsumoto-jo Castle. Looking Towards Tomorrow’s Health Matsumoto Area Headquarters Matsumoto …See details»
Kissei Pharmaceutical Co., Ltd.
Jan 23, 2025 Contract revenue from collaborations consisted of $13.0 million from Kissei Pharmaceutical Co., Ltd. (Kissei) related to an upfront fee from sublicensing olutasidenib and …See details»
Organization | Kissei Pharmaceuticals - Purdue University
Kissei Pharmaceuticals Report issue For profit Phase 2 Phase 3 Phase 4 Founded: Matsumoto Japan (1946)See details»
KISSEI PHARMACEUTICAL CO., LTD. | Member Companies | Japan ...
This page is a KISSEI PHARMACEUTICAL CO., LTD. page of JPMA. Address: 19-48 Yoshino, Matsumoto, Nagano 399-8710. Contact: Phone：+81-263-25-9081See details»
Kissei Pharmaceutical - Crunchbase Investor Profile & Investments
View contacts for Kissei Pharmaceutical to access new leads and connect with decision-makers. View All Contacts . Details. Edit Details Section. Industries . Agriculture . Biotechnology . ...See details»
Kissei Pharmaceutical 2025 Company Profile: Stock Performance ...
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span …See details»
About Kissei | English Home - KISSEI PHARMACEUTICAL CO.,LTD.
Mar 31, 2024 KISSEI PHARMACEUTICAL CO., LTD. Head Office. 19-48, Yoshino, Matsumoto, Nagano 399-8710, Japan Access Map (Google Maps) Phone +81-(0)263-25-9081 ... Capital. …See details»
Rigel Expands Relationship with Kissei to include REZLIDHIA ...
Sep 3, 2024 Kissei is a Japanese pharmaceutical company with approximately 80 years of history, specialized in the field of urology, kidney-dialysis and unmet medical needs. Kissei …See details»
キッセイ薬品工業 - Wikipedia
キッセイスペシャル（Kissei Special）は、長野朝日放送（abn）が数年おきに制作・放送しているドキュメンタリー特別番組。1994年（平成6年）から制作、長野県の自然や文化をテーマ …See details»
Kissei Pharmaceutical Co., Ltd. revenue 2023 | Statista
Mar 11, 2025 The revenue of Kissei Pharmaceutical Co., Ltd. with headquarters in Japan amounted to 75.58 billion Japanese yen in 2023. The reported fiscal year ends on March 31.See details»
Our Business | About Kissei - KISSEI PHARMACEUTICAL CO.,LTD.
“Pharmaceutical company cannot exist without R&D.” These words have been passed down at Kissei ever since the company was founded. They show that R&D is an essential and central …See details»
Kissei’s YSELTY Gains European Approval for Endometriosis
Dec 22, 2024 Kissei Pharmaceutical Co (JP:4547) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street analysts, all in …See details»
KISSEI's History | About Kissei - KISSEI PHARMACEUTICAL CO.,LTD.
Kissei Pharmaceutical Co., Ltd. Apr. 2009. Silodosin (brand name in Japan : URIEF ), a drug for the treatment of dysuria associated with benign prostatic hyperplasia, launched in the US.See details»
Jefferies Sticks to Their Hold Rating for Kissei Pharmaceutical Co ...
Mar 17, 2025 In a report released today, Miyabi Yamakita from Jefferies maintained a Hold rating on Kissei Pharmaceutical Co (KSPHF – Research Report), with a price target of …See details»
Kissei Pharmaceutical Co., Ltd. total assets 2023 | Statista
Mar 11, 2025 The total assets of Kissei Pharmaceutical Co., Ltd. with headquarters in Japan amounted to 260.93 billion Japanese yen in 2023. The reported fiscal year ends on March 31.See details»
Kissei Pharmaceutical Co., Ltd. net cash 2023 | Statista
Mar 11, 2025 The net cash of Kissei Pharmaceutical Co., Ltd. Fund flow of prime MMFs in the U.S. 2011-2016, by asset location; Fund flow of prime retail MMFs in the U.S. 2016-2024, by …See details»